Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2004 by Bispebjerg Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Bispebjerg Hospital

ClinicalTrials.gov Identifier:

NCT00206921

First received: September 13, 2005

Last updated: July 23, 2007

Last verified: December 2004

History of Changes

Tracking Information

First Received Date ^ICMJE

September 13, 2005

Last Updated Date

July 23, 2007

Start Date ^ICMJE

February 2005

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00206921 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

Official Title ^ICMJE

Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness

Brief Summary

The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment

Condition ^ICMJE

Telangiectasis
Erythema

Intervention ^ICMJE

Device: Pulsed dye laser
Device: Intense pulsed light

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

August 2005

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

18 years or older
Skin types I, II, III
No previous laser or IPL treatment for the condition

Exclusion Criteria:

Younger than 18 years old
Skin types IV, V, or VI
Pregnant or lactating women
Previous laser or IPL treatment for the condition
Recent exposure to sun or sun-beds
Treatment with oral retinoid within 6 months
Tendency to produce hypertrophic scars or keloids

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Not Provided

Contacts ^ICMJE

Contact: Merete Hædersdal, MD, PhD, DrMedSci

+45 35 31 60 02

mhaedersdal@dadlnet.dk

Location Countries ^ICMJE

Denmark

Administrative Information

NCT Number ^ICMJE

NCT00206921

Other Study ID Numbers ^ICMJE

KF-01-236/04

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Bispebjerg Hospital

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Merete Hædersdal, MD, PhD, DrMedSci

Bispebjerg Hospital

Information Provided By

Bispebjerg Hospital

Verification Date

December 2004

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top